Owlstone Medical
Matteo Tardelli, PhD, is a Senior Biomarker Scientist at Owlstone Medical. Matteo has experience in leading biomarker development in clinical programs for respiratory, inflammatory, and metabolic diseases. Prior to their current role, Matteo worked as a Senior Consultant at PreScouter, Inc., a Senior Scientist at X4 Pharmaceuticals, and held postdoctoral positions at Weill Cornell Medicine and Medical University of Vienna. Matteo has a diverse background in immunology, metabolism, and pre-clinical research, with a strong focus on developing new therapies and strategies in healthcare. Matteo's educational background includes a PhD in Immunology and Metabolism from Medical University of Vienna and a Postgraduate Degree in Endocrinology, Diabetes and Metabolism from Cornell University.
This person is not in any offices
Owlstone Medical
2 followers
A breathalyzer for disease. Breath Biopsy: The leader in non-invasive breath biomarker research. Our mission: Save 100,000 lives and $1.5B healthcare costs.